TY  - JOUR
AU  - Hurtado Carneiro, Verónica
AU  - Sanz Miguel, María Del Carmen
AU  - Roncero Rincón, Isabel
AU  - Vázquez Pérez, Patricia
AU  - Blázquez Fernández, Enrique
AU  - Álvarez García, Elvira
AU  - Rancán, Lisa
AU  - Bazán, Nicolas 
PY  - 2012
DO  - 10.1007/s12035-012-8239-z
SN  - 1559-1182
UR  - https://hdl.handle.net/20.500.14352/94940
T2  - Molecular Neurobiology
AB  - The anorexigenic peptide, glucagon-like peptide-1 (GLP-1), reduces glucose metabolism in the human hypothalamus and brain stem. The brain activity of metabolic sensors such as AMP-activated protein kinase (AMPK) responds to changes in glucose levels....
LA  - eng
M2  - 348
PB  - Springer
KW  - AMPK
KW  - Control of feeding
KW  - Antidiabetogenic agents
KW  - Hypothalamus
KW  - mTOR/S6K
KW  - Zucker rats
TI  - Glucagon-Like Peptide 1 (GLP-1) Can Reverse AMP-Activated Protein Kinase (AMPK) and S6 Kinase (P70S6K) Activities Induced by Fluctuations in Glucose Levels in Hypothalamic Areas Involved in Feeding Behaviour
TY  - journal article
VL  - 45
ER  -